-
You must submit the settlement "Proof" form attached below, in order to participate in this settlement. There is a strict deadline of September 2, 2020 by which all claims must be submitted. The instructions for submitting are included in the Proof and the Notice files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
Settlement Overview
You must register to view and download the Settlement Notice and Settlement Proof.
May 5, 2020 - The court preliminarily approved the settlement.
April 30, 2020 - A stipulation of settlement was entered by the parties.
September 27, 2019 - The court granted in part and denied in part the defendants' motion to dismiss.
February 22, 2019 - A motion to dismiss the consolidated complaint was filed.
September 14, 2018 - A consolidated complaint was filed.
March 7, 2018 - An investor in shares of Henry Schein Inc (NASDAQ: HSIC) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Henry Schein Inc in connection with certain allegedly false and misleading statements made between March 7, 2013 and February 12, 2018.
Melville, NY based Henry Schein Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners.
Henry Schein Inc Reported that its Total Revenue rose from over $10.62 billion in 2015 to over $11.57 billion in 2016 and its Net Income increased from $479.06 million in 2015 to $506.78 million in 2016. On February 12, 2018, it was reported that the Federal Trade Commission (FTC) has filed a complaint against the three largest U.S. dental supply companies in the country, including Henry Schein Inc.
The complaint alleges that the companies conspired to prevent dental groups from buying their products in bulk at a discount. Shares of Henry Schein Inc (NASDAQ: HSIC) declined on February 12, 2018 to as low as $63.01 per share. According to the complaint the plaintiff alleges on behalf of purchasers of Henry Schein Inc (NASDAQ: HSIC) common shares between March 7, 2013 and February 12, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 7, 2013 and February 12, 2018, the defendants made false and/or misleading statements and/or failed to disclose that Henry Schein Inc was engaging in unethical, anti-competitive behavior through agreements with Benco Dental Supply Company and Patterson Companies Inc, in violation of United States antitrust laws, that Henry Schein Inc engaged in such behavior, in part, to help maintain profitability in a consolidating health care industry, that these violations of U.S. antitrust laws would result in heightened scrutiny by the federal government and a lawsuit filed by the Federal Trade Commission (“FTC”), that Henry Schein Inc failed to maintain adequate internal controls, and that a result, defendants’ statements about Henry Schein Inc’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.